首页> 外文期刊>Antiviral Research >Effect of desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) on rat cytomegalovirus replication in vitro and in vivo.
【24h】

Effect of desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) on rat cytomegalovirus replication in vitro and in vivo.

机译:去铁胺(DFO)和三钠二亚乙基三胺五乙酸钙(DTPA)对大鼠巨细胞病毒体内外复制的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

Cytomegalovirus (CMV) infection is a major problem in the immunosuppressed patient. It is thought that besides direct CMV induced cell lysis, immunological damage is part of CMV pathogenesis. New antiviral drugs, which combine immunomodulating and antiviral qualities, could be beneficial. Recently, it has been described that desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) exhibit both properties. In this report the antiviral effects of both compounds against rat CMV (RCMV) are described in vitro and in vivo using a generalised and local infection model. In vitro, both compounds exhibited a significant antiviral effect, DTPA being more potent than DFO. However, in the generalised infection model no effect was seen on mortality, morbidity or presence of virus in internal organs. In rats infected subcutaneously in the hind paw, no effect was seen locally on paw thickness, presence of viral antigens and inflammatory response. In addition, these rats suffered from a generalised infection of low magnitude at 15 days post infection, although both DFO and DTPA were able to lower the level of viral replication. In conclusion, our data indicate that despite in vitro activity, in vivo usage of DFO or DTPA for acute CMV infection is not warranted.
机译:巨细胞病毒(CMV)感染是免疫抑制患者的主要问题。认为除了CMV直接诱导的细胞裂解外,免疫损伤是CMV发病机理的一部分。结合免疫调节和抗病毒特性的新抗病毒药物可能是有益的。近来,已经描述了去铁草胺(DFO)和三钠二亚乙基三胺五乙酸钙(DTPA)显示出两种性质。在该报告中,使用通用和局部感染模型在体外和体内描述了这两种化合物对大鼠CMV(RCMV)的抗病毒作用。在体外,这两种化合物均显示出显着的抗病毒作用,DTPA比DFO更有力。但是,在一般感染模型中,对内脏器官的死亡率,发病率或病毒的存在没有影响。在后爪皮下感染的大鼠中,爪的厚度,病毒抗原的存在和炎症反应均未见局部影响。此外,尽管DFO和DTPA均能够降低病毒复制水平,但这些大鼠在感染后15天遭受了轻度的全身感染。总之,我们的数据表明,尽管具有体外活性,但仍不保证DFO或DTPA在体内用于急性CMV感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号